期刊
CASE REPORTS IN DERMATOLOGY
卷 3, 期 2, 页码 103-106出版社
KARGER
DOI: 10.1159/000328796
关键词
Cutaneous sarcoidosis; Systemic sarcoidosis; Sarcoidosis treatment; Adalimumab; TNF-alpha antagonist
类别
资金
- Department of Dermatology, University Hospital of Zurich
Depending on the location, dermatoses can produce blemishes that severely impair quality of life and require highly effective treatment that is otherwise used for extensive skin involvement. We report the case of a 39-year-old, otherwise healthy male disfigured by an 8 x 7-cm hypopigmented and centrally atrophic annular plaque with erythematous indurated borders in an area of scar tissue on his forehead. Skin biopsies revealed noncaseating granulomas, and hilar involvement was identified, leading to the diagnosis of systemic sarcoidosis stage II with cutaneous involvement. The lesions proved resistant to multiple therapies, but responded within 4 months to adalimumab with regression of the lesion and inflammatory infiltrate. The visual analogue scale of disease activity decreased from 7/10 to 3.5/10, and the Dermatology Life Quality Index from 16/30 to 3/30 points. In conclusion, TNF-alpha inhibition can control inflammation and disfigurement by cutaneous sarcoidosis and restore quality of life.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据